VNLPY

 
Sponsored ADR (1 ADS : 2 Ordinary) International Reporting
OTC Pink Current Information
Contact Info
  • 100 Berkshire Place
  • Wharfedale Rd.
  • Winnersh RG41 5RD
  • United Kingdom

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status International Reporting: LSE - London Stock Exchange
Latest Report Dec 31, 2005 20-F
CIK 0000851616
Fiscal Year End 12/31
OTC Marketplace OTC Pink Current
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: United Kingdom
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Ian Garland CEO
David Mackney CFO
Company Directors
Not Available
Company Notes
  • Formerly=British Biotech Plc until 10-03
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
VNLPY Security Details Other Company Securities
Share Structure
Market Value1 $47,302,500 a/o Dec 02, 2016
Authorized Shares Not Available
Outstanding Shares 99,584,210 a/o Jul 21, 2011
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
BNY Mellon
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
VER - LSE - London Stock Exchange - Qualified
Short Selling Data
Short Interest 0 (-100%)
Dec 15, 2015
Significant Failures to Deliver No

1Market Value calculated only for respective security